Cardiogen 20 mg: research material

Buy Cardiogen 20 mg for laboratory research, supplied as lyophilized powder in one boxed 3 mL vial.

Cardiogen is a synthetic tetrapeptide studied in organotypic myocardial tissue cultures. Its reference sequence is AEDR: alanine-glutamic acid-aspartic acid-arginine.

Choose the material and presentation

The four residues and their order identify the reference peptide. AEDR differs from the three-residue AED sequence associated with Cartalax. A shared sequence fragment does not make those materials interchangeable.

The original development record describes the Ala-Glu-Asp-Arg sequence. Use the supplied product records to check the identity and any stated salt or counterion for the lot being considered; a reference sequence alone does not verify those details.

Cardiogen in myocardial tissue cultures

The original study compared Cardiogen and individual amino acids in myocardial tissue cultures from rats aged 3 and 24 months. Cardiogen stimulated proliferation in cultures from both age groups and reduced expression of p53, a protein involved in cell-cycle regulation.

These were tissue-culture measurements. They do not establish improved cardiac function in people or show that a separately supplied vial will reproduce the findings. When comparing research, retain the age group, tissue model and measured endpoint rather than treating “cardiac support” as an equivalent description.

Original study

Product records and batch reports

Review the available files in the product documentation section. Match the material name and lot, then distinguish identity testing, reported purity and measured peptide content. A purity result alone does not establish the amount in a vial.

The labeled 20 mg is an amount of material, not a solution concentration. Check preparation requirements against your laboratory method and the applicable product records.